SWOT Analysis

What is SWOT Analysis

Shilpa Medicare Ltd.

Strengths 23 S

Weakness 8 W

Opportunity 2 O

Threats 2 T

What is SWOT Analysis ?

Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.

These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.

• Strengths
• Weakness
• Opportunity
• Threats

• Strong Momentum: Price above short, medium and long term moving averages
• Consistent Highest Return Stocks over Five Years
• Relative Outperformance versus Industry over 1 Month
• Growth Stars: Strongest Annual EPS Performers
• Stocks whose current price is 20% higher than week low, and more than previous close
• Expensive Performers (DVM)
• Annual Profit Growth higher than Sector Profit Growth
• PEG lower than Industry PEG
• High Momentum Scores (Technical Scores greater than 50)
• Relative Outperformance versus Industry over 1 Week
• Relative Outperformance versus Industry over 1 Month
• Overbought by Money Flow Index (MFI)
• Effectively using its capital to generate profit - RoCE improving in last 2 years
• Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
• Efficient in managing Assets to generate Profits - ROA improving since last 2 year
• Companies with Low Debt
• Annual Net Profits improving for last 2 years
• Book Value per share Improving for last 2 years
• Stock gained more than 20% in one month
• Highest Recovery from 52 Week Low
• Top Gainers
• Stocks near 52 Week High with Significant Volumes
• Stocks Outperforming their Industry Price Change in the Quarter

• PE higher than Industry PE
• Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)
• High PE (PE > 40)
• Stocks with Expensive Valuations according to the Trendlyne Valuation Score
• Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
• Declining Net Cash Flow : Companies not able to generate net cash
• Increasing Trend in Non-Core Income
• High promoter stock pledges

• Mutual Funds Increased Shareholding in Past Month
• FII / FPI or Institutions increasing their shareholding

• MFs decreased their shareholding last quarter
• US FDA Warning Letter